Clinicians prescribing GLP-1 agents should ask about sexual function and consider medication review if new anorgasmia appears.

GLP-1 drugs such as Ozempic and Wegovy may extend the lives of colon cancer patients, according to a major UC San Diego study ...

In a world that chases fitness and wellness amidst the hustle of daily lives, weight loss jabs have become the magic pills ...

Novo Nordisk NVO is a dominant player in the cardiometabolic space, which markets its blockbuster semaglutide-based (GLP-1) ...

The nausea and other gastrointestinal side effects of weight loss drugs like Novo Nordisk’s Wegovy or Eli Lilly’s Zepbound will limit how much these drugs can help patients and stunt the overall ...

As Ozempic and Wegovy use increases so does the incidence of facial sagging, known as "Ozempic face." Now, brands are developing products specifically for these patients. Here's what you need to know.

A NEW weight loss drug may offer a tempting alternative to popular GLP-1 drugs like Ozempic and Wegovy. The once-weekly ...

Adults with atrial fibrillation with overweight or obesity were less likely to experience recurrent atrial arrhythmia when ...

Q3 2025 Earnings Call Transcript November 10, 2025 Wave Life Sciences Ltd. misses on earnings expectations. Reported EPS is $ ...

Phase 2 data show significant reductions in nausea and vomiting that can cause patients to discontinue GLP-1s.

Adocia (Euronext Paris: FR0011184241 – ADOC, the "Company"), a clinical-stage biopharmaceutical company focused on the ...